Site Search
Search Results
Senate Votes to Remove Barriers to Precision Treatments
INDIANAPOLIS, IN – This afternoon, the Indiana Senate passed Senate Bill 273, which would ensure biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments, is covered by more insurance ... is a statement from Allie Kast, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in Indiana: "Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s specific type of ...
Legislature Votes to Remove Barriers to Precision Treatments
... sent Senate Bill 273 to the Governor’s desk for signing. This legislation will ensure that more insurance plans in the Hoosier state cover biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments. “Biomarker testing has given me better, more effective treatment options, a better chance of surviving cancer and more time with my family,” said ...
Cancer Patients and Survivors Rally at the Statehouse
... and death by improving access to care and reducing tobacco use. Advocates asked lawmakers to support legislation that would improve access to biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state-regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role ...
It is Time to Reduce the Burden of Cancer on Hoosiers
... to prioritize passing legislation to ease the burden of cancer on Hoosiers. “ACS CAN calls on the legislature to increase access to biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state-regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role ...